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Thispaperinvestigatedtheeﬀectivenessofaninpatientmovementdisordersprogramforpatientswithatypicalparkinsonism,who
typically respond poorly to pharmacologic intervention and are challenging to rehabilitate as outpatients. Ninety-one patients
with atypical parkinsonism participated in an inpatient movement disorders program. Patients received physical, occupational,
and speech therapy for 3hours/day, 5 to 7 days/week, and pharmacologic adjustments based on daily observation and data.
Diﬀerences between admission and discharge scores were analyzed for the functional independence measure (FIM), timed up
and go test (TUG), two-minute walk test (TMW), Berg balance scale (BBS) and ﬁnger tapping test (FT), and all showed signiﬁcant
improvement on discharge (P>. 001). Clinically signiﬁcant improvements in total FIM score were evident in 74% of the patients.
Results were similar for ten patients whose medications were not adjusted. Patients with atypical parkinsonism beneﬁt from an
inpatient interdisciplinary movement disorders program to improve functional status.
1.Introduction
Atypical parkinsonism is used to describe disorders charac-
terizedbyparkinsonism—tremor,rigidity,akinesia,andpos-
turalinstability—butnotcausedbyParkinson’sdisease(PD).
These disorders often include other prominent features. The
term includes progressive supranuclear palsy (PSP), multiple
system atrophy (MSA), Lewy body dementia (LBD), corti-
cobasal degeneration (CBD), vascular parkinsonism, drug-
induced parkinsonism, and parkinsonism secondary to in-
fection and other causes. PSP is characterized by parkinson-
ism along with a supranuclear vertical gaze palsy and early
onset of balance problems and falls. The hallmark features of
MSA include parkinsonism, autonomic instability, and cere-
bellar and corticospinal deﬁcits. LBD has similar pathology
to PD; however, accumulation of Lewy bodies in areas out-
side the substantia nigra leads to hallucinations, cognitive
impairment and dementia prior to the onset of parkinson-
ism. Features of CBD include asymmetric parkinsonism,
apraxia, alien limb phenomenon, aphasia, and sensory de-
ﬁcits. Vascular parkinsonism is due to lacunar infarcts in the
basal ganglia and can be distinguished from PD by an abrupt
onset or stepwise deterioration and development of parkin-
sonismandevidenceofneurovasculardisease.Drug-induced
parkinsonism is often due to antipsychotics or antiemetics
and usually resolves with cessation of the oﬀending drug
[1, 2].
Treatment of PD involves medications that increase dop-
amine in the basal ganglia. However, there has been less suc-
cess with pharmacologic treatment in atypical parkinsonism
[1, 3–5]. Previous studies have shown physical therapy to be
an eﬀective adjunctive treatment in patients with PD [6, 7]
buttherehaveonlybeenahandfulofcasereportsandstudies
investigating the eﬃcacy of nonpharmacologic therapy in
atypical parkinsonism patients.2 Parkinson’s Disease
Case reports and studies have shown subjective and ob-
jective improvements in gait, balance, and patient safety in
patients with PSP [8–12] and in a patient with mixed CBD
and PSP [13]. Similar improvements in gait, balance, trans-
fers,andstabilitywereseenincasereportsofphysicaltherapy
intervention in patients with MSA [14, 15]. Timed up and
go, functional reach test, 360-degree turn, and 50 foot timed
walk are examples of some of the improved objective meas-
ures. Another case report showed improvement in activities
of daily life (ADLs) and ﬁnger manipulation after repetitive
ﬁngerexercises in a patient withCBD [16].Asmallpilot ran-
domized controlled trial showed signiﬁcant improvement in
MSA patients after receiving individualized outpatient occu-
pational therapy [17].
Regarding intensive inpatient programs, a prior study by
Ellis et al. investigated the eﬀectiveness of an inpatient re-
habilitation program for people with PD. In the study, medi-
cation was adjusted and interdisciplinary rehabilitation pro-
gram was provided to optimize patients’ functional ability.
Signiﬁcant improvements were noted in all outcome mea-
sures.Patientswhodidnothavechangesmadetotheirmedi-
cations also showed signiﬁcant improvements in total,
motor, and cognitive functional independence measure
(FIM) scores [18].
The purpose of this study was to investigate the eﬀec-
tiveness of an inpatient movement disorders program in im-
proving functional status for patients with atypical parkin-
sonism and to determine whether or not these ﬁndings
wereclinicallymeaningful.Wehypothesizedthatpeoplewith
atypical parkinsonism would show statistically and clinically
signiﬁcant improvements in functional status after partici-
pating in such a program.
2. Methods
2.1. Design and Subjects. A pretest-posttest design was used
to determine the eﬀectiveness of a movement disorder pro-
gramforpatientsadmittedtoaninpatientrehabilitationhos-
pital with the diagnosis of atypical parkinsonism. Patients
were admitted from home, acute care facilities, skilled nurs-
ing facilities, or assisted living between January 2004 and
August2008.Theycarrieddiagnoses,determinedbyaneuro-
logist specializing in movement disorders, which fall under
the term “atypical parkinsonism” as described above. They
were at least 18 years old and were given a Hoehn and Yahr
stageItoVforclassiﬁcationofPD.Atotalof91subjectswere
admittedtotheprogram.Baselinecharacteristicsarelistedin
Table 1.
2.2. Outcome Measures. Primary outcomes were FIM total
score. Secondary outcomes included FIM motor score, FIM
cognitive score, 2-minute walk test (TMW), Timed “up and
go” test (TUG) Berg balance score, and ﬁnger tapping test
(FT).
The FIM is a widely used 18-item assessment of disability
among inpatient rehabilitation patients. The FIM measures
abilitytoperformbasiclifeactivities,suchasself-care,sphin-
cter control, transfers, locomotion, communication, and
Table 1: Patient baseline characteristics.
Characteristic
Age—y, mean (SD) n = 91 76.6 (7.7)
Disease duration—y, mean (SD) n = 91 5.7 (4.4)
Sex no. (%) men/women n = 91 53 (58.2)/38 (41.8)
Race no. (%) white n = 91 84 (92.3)
Education no. (%) ≤ bachelor’s/
>bachelor’s n = 75 51 (56)/24 (26.4)
Hoehn and Yahr stage no. (%) n = 85
I0 ( 0 )
II 0 (0)
III 26 (28.6)
IV 43 (47.3)
V 16 (17.6)
Length of stay—d, mean (SD) 24.4 (11.9)
Diagnosis no. (%) n = 91a
Vascular parkinsonism 25 (27.5)
MSA 19 (20.9)
PSP 4 (4.4)
Medication related 2 (2.2)
LBD 1 (1.1)
CBD 1 (1.1)
Toxin 1 (1.1)
Unknown 38 (41.8)
aMSA: multiple system atrophy, PSP: progressive supranuclear palsy, LBD:
Lewy body dementia, and CBD: corticobasal dementia.
social cognition. Each item is scored on a scale from 1 to 7,
in which 1 is patient requires total assistance to complete the
taskand7iscompleteindependence.TheFIMcanbedivided
into 2 sections: motor (13 items) and cognitive (5 items). It
has been shown to have good reliability and validity [19].
The TMW is performed by asking subjects to walk as far
as they can in 2 minutes. Patients with PD have been shown
to cover less distance than age-matched controls [20].
The TUG assesses a patient’s ability to transfer from sitt-
ing to standing, ambulate, and make a turn. Patients are tim-
ed while rising from a chair, walking 3m, turning, walking
backtothechair,andsittingdown.Ithasbeenshowntohave
high interrater reliability for subjects with PD [21]. Subjects
were allowed to use an assistive device if necessary for the
TMW and the TUG.
The BBS is a 14-item scale assessing balance while sitting,
standing, turning, and reaching forward. Items are rated
from 0 to 4, with 0 meaning the subject needs assistance or is
unable to perform the task and 4 meaning the subject can
perform the task safelyand independently. It has been shown
to be reliable and valid in patients with PD [22, 23]. Minimal
detectable change (MCD) has been found to be +/−6 points
among patients who have suﬀered a stroke [24]a n d+ /−5
points in patients with PD [25].
The FT is a timed test useful in assessing the impact of
bradykinesia on rapid alternating movements of the upper
extremity.Twobuttonsareattachedtoacounter30cmapart.Parkinson’s Disease 3
Subjects are asked to alternate tapping each button with their
left hand for one minute. The sum of the taps is the score for
that hand. The test is repeated with the right hand. The FT
has been shown to have good validity and reliability and is
able to distinguish normal subjects from those with PD [26].
2.3. Intervention. A multidisciplinary team consisting of
neurologists specializing in movement disorders and neuro-
rehabilitation, physical therapists, occupational therapists,
speech-language pathologists, nurses, and case managers
provided a comprehensive rehabilitation program for pa-
tients admitted to the hospital.
All outcome measures were obtained at admission and
discharge, as well as daily measurements of TMW and TUG
at the peak and troughs of medication cycles. The same ther-
apists administered interventions and outcome measures.
Weekly rounds were conducted to allow the whole team to
evaluate the data and discuss the patients’ status. Decisions
regarding changes to medications or rehabilitation interven-
tions were made at this time. Subjects’ responses to medica-
tionadjustmentswerediscussedfurtheratweeklymovement
disorder meetings. Adjustments were made to subjects’ ther-
apy and medications during the entire length of stay at the
hospital. Medication adjustments included increases or de-
creases in Parkinson’s disease medications to optimize peak
performance. Those medications included carbidopa/ lev-
odopa, monoamine oxidase inhibitors, catechol-o methyl-
transferase inhibitors and amantadine.
Subjects received individually tailored physical, occupa-
tional, and speech therapy for a minimum of 3 hours per day
for 5 to 7 days per week. Therapy was provided on an indi-
vidual and group basis. Interventions included external cue-
ing to improve gait speed, step length and cadence [27–30],
cognitive movement strategies during task-based training to
improve mobility, balance and transfers [6, 31–33], resistive
exercises [34], exercises for joint mobility [35, 36], and
speech therapy to improve voice volume and clarity [37, 38].
A more detailed description of the intervention is provided
in Table 2.
2.4. Data Analysis. Means, standard deviations, and fre-
quency distributions were calculated for subjects’ baseline
characteristics, length of stay, and disposition. The eﬃcacy
of the intervention was evaluated by comparing admission
anddischargemeanscoresforeachoftheoutcomemeasures.
Two-tailed paired t tests were conducted with an alpha level
setat0.05.ABonferroni-adjustedtypeIerrorrate(α=0.007)
was applied to all t tests. Results were calculated for patients
who received rehabilitation along with PD medication ad-
justments and for patients who received rehabilitation only.
Clinically signiﬁcant improvement was determined based on
a total FIM score change of ≥22, which has been associated
with the minimal clinically important diﬀerence in people
who have suﬀered a stroke [39]. In this study a change from
admission of more than 22 was considered to be clinically
meaningful.
3. Results
3.1. Subjects. Ninety-one subjects with atypical parkinson-
ism underwent rehabilitation therapy. Average age at admis-
sion was 76.5 years (SD 0.81), and they had been carrying
the diagnosis of parkinsonism for an average of 5.7 years
(SD 0.55). Of the 91 subjects with atypical parkinsonism, 25
(27.5%) had vascular parkinsonism, 19 (20.9%) had MSA, 4
(4.4%) had PSP, and the remaining cases were either medi-
cation related, due to LBD, CBD, toxin exposure or were un-
known. Eighty-ﬁve of the subjects were Hoehn and Yahr
stages III-V. Six subjects were not evaluated using Hoehn
and Yahr (Table 1). The rehabilitation team made changes
to 81 subjects’ medications while receiving physical therapy.
Ten subjects underwent physical rehabilitation only with no
changes to their medications. Length of stay varied from one
to six weeks with an average stay of 2.5 weeks.
3.2. Outcomes for All Patients. Statistically signiﬁcant im-
provements were made in all outcome measures over the
course of the rehabilitation program (Table 3). Total FIM
score increased 29.5 points (95% CI = 26.4–32.5). Addition-
ally, motor FIM improved 25.9 points (95% CI = 23.4–28.5)
and cognitive FIM improved 3.5 points (95% CI = 2.6–4.4).
TUGdecreasedby39.4seconds(95%CI =20.6–58.2),TMW
lengthened by 63.5 feet (95% CI = 44.3–82.9), and Berg
balance scale scores improved 7.5 points (95% CI = 4.3–
10.6). Left and right ﬁnger tapping improved by 11.5 taps
(95% CI = 6.7–16.1) and 10.8 taps (95% CI = 5.8–16.1), res-
pectively.
Previous studies have shown the minimal clinically im-
portant diﬀerence of total FIM to be 22 [39]. Using this cut-
oﬀ, sixty-ﬁve (74%) patients made clinically meaningful im-
provements in total FIM.
3.3. Outcomes for Patients Receiving Rehabilitation Only and
No Changes to Medication. Statistically signiﬁcant improve-
ments were made in all but left ﬁnger tapping for the 10
patients who received rehabilitation only (Table 4). Analysis
showed an improvement of 32.1 (95% CI = 22.8–41.3) for
total FIM, 28.6 (95% CI = 19.8–37.3) for motor FIM, and
3.5 (95% CI = 1.7–5.2) for cognitive FIM. TUG decreased by
52 seconds on average (95% CI = 13.1–91.0), TMW length
increased by 76 feet (95% CI = 27.4–124.5), and right ﬁnger
tapping improved by 19.6 taps (95% CI = 3.4–25.7). Left
ﬁnger tapping increased on average 7.8 taps, but results were
not statistically signiﬁcant (95% CI = −9.7–25.4).
4. Discussion
This study investigated the eﬀectiveness of an interdisci-
plinary inpatient rehabilitation program for patients with
atypical parkinsonism. Our results showed improvements in
t o t a lF I M ,m o t o rF I M ,c o g n i t i v eF I M ,T M W ,T U G ,B B S ,a n d
leftandrightFT.Amongpatientswhoreceivedrehabilitation
only, without changes to their medication regimens, statisti-
cally signiﬁcant improvement in all but left FT was observed.
Clinically meaningful improvement, deﬁned by a change in4 Parkinson’s Disease
Table 2: Description of interventions.
Functional training
Rolling from supine position to sitting position and from sitting position to supine position.
Transferring from sitting position to standing position, from chair to bed, and from chair to toilet.
Dressing and grooming.
Balance: reactive and anticipatory within functional contexts.
Gait training
Walking with external auditory cues from a metronome to optimize gait speed and cadence;
increasing cadence by 10% over baseline and progressing until cadence approaches normal or
until subject reaches maximum capacity.
Reducing freezing (context speciﬁc: doorways, thresholds, and narrow spaces) with visual cues in
the form of lines on the ﬂoor from tape or laser beams.
Reducing freezing (context speciﬁc: doorways, thresholds, and narrow spaces) with visual cues in
the form of lines on the ﬂoor from tape or laser beams.
Improving adaptation (various walking surfaces, obstacles in the environment, starting and
stopping, and turning head while walking).
Curb negotiation and stair climbing.
Range of motion, ﬂexibility,
strengthening exercises
Range of motion (increase trunk extension and rotation).
Stretching (hip ﬂexor, hamstring, and gastrocnemius muscles).
Strengthening (trunk and hip postural muscles and knee and ankle extensor muscles).
Speech exercises Exercises to improve vocal rate control.
Exercises to improve phonation.
Table 3: All patients.
Measure (n)a Admission mean (SD) Discharge mean (SD) Change (95% CI)
Total FIM (88) 41.3 (15.7) 70.8 (21.4) 29.5 (28.4, 32.5)
Motor FIM (88) 23.6 (11) 49.6 (16.6) 25.9 (23.4, 28.5)
Cognitive FIM (87) 17.7 (6.1) 21.2 (5.8) 3.5 (2.6, 4.4)
TUG (60) 81.5s (89.4) 42.0s (46.9) −39.4s (−20.6, −28.2)
TMW (60) 138.9ft (76.9) 202.5ft (96.9) 63.5ft (44.2, 82.9)
BBS (28) 22 (12.2) 29.5 (13.4) 7.5 (4.3, 10.6)
Left FT (51) 60.2 (23.3) 71.7 (24.8) 11.5 (6.7, 16.1)
Right FT (50) 68.3 (27) 79.3 (30) 10.9 (5.8, 16.1)
aFIM: functional independence measure, TUG: timed up and go, TMW: 2-minute walk, BBS: berg balance scale, and FT: ﬁnger tap.
total FIM of greater than 22, was also observed in 74% of
patients. These results imply that patients with atypical par-
kinsonism can show signiﬁcant improvement in function
after receiving intensive inpatient multidisciplinary therapy
including rehabilitative and pharmacologic interventions.
Patients with atypical parkinsonism are diﬃcult to man-
age on an outpatient basis. The complexity of their symp-
toms, the added cognitive and autonomic deﬁcits, the poor
response to most PD pharmacological agents, and the rela-
tively rapid decline in status contribute to the challenges in
managing these patients particularly as the disease progress-
es. This study highlights the beneﬁts of an interdisciplinary
rehabilitation program in addition to medication adjust-
ments in an inpatient setting, where patients could be ob-
served over a 24-hour period, 7 days per week by health care
professionals with expertise in movement disorders. Objec-
tive measures taken daily during peak and troughs of medi-
cation cycle allowed an objective, systematic assessment
of function. This data was used to guide the decision-
making process regarding pharmacological adjustments and
the focus of rehabilitation strategies.
Strengths of our study include the large sample size, the
variety of disorders, and the advanced disability stages of
the patients. Other studies investigating the eﬀectiveness of
rehabilitation have been case reports, small pretest-posttest
trials with a sample size of 19 or less, and a pilot RCT
with a sample size of 17 [6, 8–10, 12–15]. In addition, most
of the studies included subjects with PSP, whereas our study
sampled across categories of atypical parkinsonism and
included primarily vascular parkinsonism and MSA. Our
patients were also at higher levels of disability and all were
Hoehn and Yahr stages III to V, suggesting that functional
gains can be made in these patients with complex symptoms
in later stages of the disease.
Limitations of the study include lack of a control group
and prescribing rehabilitation while simultaneously chang-
ing medications. We are unable to distinguish what eﬀects
were due purely to physical rehabilitation. However, our
smaller group of 10 patients who received rehabilitation only
did show signiﬁcant improvement, but larger studies should
be conducted to address the particular eﬀects of rehabilita-
tion alone. It is also diﬃcult to assess whether the intensiveParkinson’s Disease 5
Table 4: Patients receiving rehabilitation only.
Measure (n)a Admission mean (SD) Discharge mean (SD) Change (95% CI)
Total FIM (10) 38.3 (13.4) 70.4 (23.4) 32.1 (22.8, 41.3)
Motor FIM (10) 21.2 (7.8) 49.6 (17.6) 28.6 (19.8, 37.2)
Cognitive FIM (10) 17.1 (6.1) 20.6 (6.1) 3.5 (1.7, 5.2)
TUG (10) 83.4s (61.5) 31.3s (10.1) −52.1s (−13.7, −91.0)
TMW (9) 114.4ft (77.6) 190.4ft (68.4) 76.0ft (27.4, 124.5)
Left FT (8) 61.5 (19.8) 69.3 (13.4) 7.8 (−9.7, 25.4)
Right FT (8) 67.2 (24.8) 86.8 (24.9) 19.6 (3.4, 35.7)
aFIM: functional independence measure, TUG: timed up and go, TMW: 2-minute walk, BBS: berg balance scale, and FT: ﬁnger tap.
nature of the program itself had any eﬀect on the subjects’
improvement.Thehigherfrequencyofassessmentsandther-
apysessionsinaninpatientsettingmayhavecontinuedtothe
improvements observed. Factors such as treatment intensity,
the availability of objective data for treatment decisions
and goal setting, and the expertise and frequent commu-
nication of the interdisciplinary team were not individually
assessed. Further studies comparing specialized interdisci-
plinary movement disorder rehabilitation programs such as
the program described in this study with more traditional
standard rehabilitative care would help clarify this question.
Another limitation of our study is the lack of long-term
followup data. It is unknown if the gains made during the
rehabilitation admission were sustained following discharge.
One study of patients with idiopathic PD in Hoehn and
Yahr stages II and III who participated in an inpatient exer-
cise training and muscle strengthening program sustained
improvements in quality of life at follow-up [40]. Lastly, the
gainsinthetotalFIMusedtoassessclinicallymeaningfulim-
provement were extrapolated from the stroke literature [39],
as this has not been derived in parkinsonian patients.
Whileourstudydemonstratedthatpatientswithatypical
parkinsonism can beneﬁt from an intensive inpatient rehabi-
litation program, further studies are needed to look at the
long-term gains. In addition, research is needed to assess
the eﬃcacy of inpatient rehabilitation programs on atypical
parkinsonism patients with earlier stages of disease and their
eﬀect on the progression of their disorders.
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